100 + INNOVATIONS
Antimicrobial Resistance Hub
Providing an integrated, multistakeholder platform to address industry-identified research priorities and accelerate innovation
Learn More
Research Project
Challenge
Antimicrobial Resistance( AMR) is one of the greatest scientific challenges of the 21st century. It requires urgent investment to develop low-cost, implementable technologies capable of slowing the global emergence of AMR. Sexually transmitted bacteria are an exemplar of the problem of AMR and a critical area of concern.
Solution
The hub partnership involves 20 organisations, including key stakeholders. The research focuses on sexually transmitted infections, which are increasingly resistant to antibiotics and have few alternatives in the pipeline.
Investigators are developing novel diagnostics, identifying tools to detect active infections, improving treatment and engaging stakeholders to optimise fit-for-purpose solutions. The team collaborates to generate evidence that informs business case strategies, maximises product adoption and ensures market share sustainability, supporting long-term public health outcomes.
Target customers / end-users
• clinicians and health care
• companies and laboratories developing antimicrobials, diagnostic and point-of-care technologies
• policymakers and health system implementers.
Progress
• > AU $ 9m funding, including ARC grant, partner cash and in-kind contribution
• early development of secondgeneration, resistance-guided therapy tests using multiplex technology
• translation efforts toward pointof-care platforms for clinical and commercial use.
Lab validated
TRL 3
Multidisciplinary team
Healthy Living
The Hub fosters multidisciplinary collaborations across sectors to develop integrated solutions that address barriers to the commercialisation of diagnostic and pharmaceutical antimicrobial stewardship tools.
• 69